Chec Approximately 14 million Americans are addicted to drugs and alcohol. The federal government estimates that these addicts cost the U.S. economy $300 billion in medical expenses and lost productivity. Despite the enormous potential market, many biotech companies have shied away from funding research and development (R&D) initiatives to find a cure for drug and alcohol addiction. Your firm - 8 Drug Abuse Sciences (DAS) - is a notable exception. It has spent $245 million to date working on a cure, but is now at a crossroads. It points can either abandon its program or invest another $45 million today. Unfortunately, the firm's opportunity cost of funds is 9 percent and it will take another five years before final approval from the Federal Drug Administration is achieved and the product is actually sold. Expected (year-end) profits from selling the drug are presented in the accompanying table. eBook What is the net present value of the project? References Instructions: Enter your response rounded to the nearest penny (two decimal places). Use a negative sign (-) where appropriate $ L Should DAS continue with its plan to bring the drug to market, or should it abandon the project? (Click to select) v Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 $0 $0 $0 $0 $11, 800, 900 $14, 100,000 $16, 300,000 $18, 500,000 $20, 400, 000